SE7606689L - Forfarande for framstellning av tetrazoylderivat av prostaglandiner - Google Patents

Forfarande for framstellning av tetrazoylderivat av prostaglandiner

Info

Publication number
SE7606689L
SE7606689L SE7606689A SE7606689A SE7606689L SE 7606689 L SE7606689 L SE 7606689L SE 7606689 A SE7606689 A SE 7606689A SE 7606689 A SE7606689 A SE 7606689A SE 7606689 L SE7606689 L SE 7606689L
Authority
SE
Sweden
Prior art keywords
tetrazoyl
prostaglandins
derivatives
procedure
preparation
Prior art date
Application number
SE7606689A
Other languages
English (en)
Other versions
SE421525B (sv
Inventor
H-J E Hess
T K Schaaf
L J Czuba
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7606689L publication Critical patent/SE7606689L/sv
Publication of SE421525B publication Critical patent/SE421525B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7606689A 1971-09-01 1976-06-11 Vissa angivna tetrazolderivat till anvendning for framstellning av vissa prostaglandiner SE421525B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17710271A 1971-09-01 1971-09-01

Publications (2)

Publication Number Publication Date
SE7606689L true SE7606689L (sv) 1976-06-11
SE421525B SE421525B (sv) 1982-01-04

Family

ID=22647201

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7211233A SE409032B (sv) 1971-09-01 1972-08-30 Forfarande for framstellning av tetrazolylderivat av prostaglandiner
SE7606689A SE421525B (sv) 1971-09-01 1976-06-11 Vissa angivna tetrazolderivat till anvendning for framstellning av vissa prostaglandiner
SE7606691A SE424185B (sv) 1971-09-01 1976-06-11 4-(tetrazol-5-yl)-butyltrifenylfosfoniumbromid, anvendbart vid framstellning av prostaglandinanaloger samt forfarande for framstellning derav
SE7606690A SE421526B (sv) 1971-09-01 1976-06-11 Vissa angivna furanderivat till anvendning for framstellning av vissa prostaglandiner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7211233A SE409032B (sv) 1971-09-01 1972-08-30 Forfarande for framstellning av tetrazolylderivat av prostaglandiner

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE7606691A SE424185B (sv) 1971-09-01 1976-06-11 4-(tetrazol-5-yl)-butyltrifenylfosfoniumbromid, anvendbart vid framstellning av prostaglandinanaloger samt forfarande for framstellning derav
SE7606690A SE421526B (sv) 1971-09-01 1976-06-11 Vissa angivna furanderivat till anvendning for framstellning av vissa prostaglandiner

Country Status (12)

Country Link
JP (1) JPS5724348B2 (sv)
AR (4) AR197304A1 (sv)
AT (3) ATA51974A (sv)
CA (1) CA978939A (sv)
DK (1) DK144730C (sv)
ES (3) ES406250A1 (sv)
FI (1) FI55497C (sv)
FR (3) FR2283136A1 (sv)
IL (3) IL48544A (sv)
PH (3) PH10023A (sv)
SE (4) SE409032B (sv)
ZA (1) ZA725827B (sv)

Also Published As

Publication number Publication date
SE424185B (sv) 1982-07-05
DK144730C (da) 1982-10-18
ES417557A1 (es) 1976-06-16
FR2283134B1 (sv) 1978-05-12
AT335079B (de) 1977-02-25
SE409032B (sv) 1979-07-23
FR2283147A1 (fr) 1976-03-26
JPS5724348B2 (sv) 1982-05-24
FI55497C (fi) 1979-08-10
ATA743472A (de) 1976-06-15
FR2283136A1 (fr) 1976-03-26
PH10416A (en) 1977-03-16
AR199574A1 (es) 1974-09-13
IL40183A0 (en) 1972-10-29
SE421526B (sv) 1982-01-04
IL48544A (en) 1977-06-30
JPS4834165A (sv) 1973-05-16
AT327219B (de) 1976-01-26
AR199784A1 (es) 1974-09-30
PH10023A (en) 1976-07-13
IL48544A0 (en) 1976-01-30
AR197304A1 (es) 1974-03-29
IL40183A (en) 1977-06-30
FI55497B (fi) 1979-04-30
ZA725827B (en) 1973-06-27
FR2283134A1 (fr) 1976-03-26
FR2283136B1 (sv) 1978-05-12
FR2283147B1 (sv) 1978-05-12
DK144730B (da) 1982-05-24
ATA51974A (de) 1975-04-15
ES406250A1 (es) 1976-06-01
CA978939A (en) 1975-12-02
PH10443A (en) 1977-03-25
ES417558A1 (es) 1976-06-16
SE421525B (sv) 1982-01-04
AR199573A1 (es) 1974-09-13
SE7606690L (sv) 1976-06-11
SE7606691L (sv) 1976-06-11

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE406197B (sv) Analogiforfarande for framstellning av 4-aminokinazolinderivat
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE393376B (sv) Forfarande for framstellning av pyrimidinonderivat
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE409858B (sv) Forfarande for framstallning av vissa angivna aminoalkylfenylacetonitrilderivat
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE394680B (sv) Forfarande for framstellning av cykliska fosfamidderivat
SE385482B (sv) Forfarande for framstellning av basiskt substituerade 3-bensoyl-benso(b)tiofen-derivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE7605364L (sv) Forfarande for framstellning av antracenderivat
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
NO136409C (no) Fremgangsm}te for fremstilling av aryloksyalkyl-morfolinderivater
SE387948B (sv) Forfarande for framstellning av tiofen